论文部分内容阅读
目的:分析舒普深与头孢哌酮治疗小儿肺炎的临床疗效。方法:将73例小儿肺炎患儿随机分为治疗组(38例)和对照组(35例),治疗组以舒普深治疗,对照组以头孢哌酮治疗,分析两组患儿治疗的临床效果。结果:治疗组治疗效果总有效率100%明显高于对照组的治疗总有效率82.9%,治疗组住院时间明显少于对照组住院时间(P<0.05)。两组不良反应对比(P>0.05)。结论:舒普深治疗小儿肺炎的临床疗效值得肯定,优于头孢哌酮治疗效果,安全有效,值得临床推广极应用。
Objective: To analyze the clinical effects of Shu Pu Shen and cefoperazone in the treatment of children pneumonia. Methods: Seventy-three children with pneumonia were randomly divided into treatment group (38 cases) and control group (35 cases). The treatment group was treated with Shu Pu Shen, the control group was treated with cefoperazone, the clinical treatment of two groups of children effect. Results: The total effective rate of the treatment group was significantly higher than that of the control group (100%). The total effective rate of the treatment group was 82.9%. The hospitalization time of the treatment group was significantly less than that of the control group (P <0.05). Adverse reactions between the two groups (P> 0.05). Conclusion: Shu Pu deep treatment of children with pneumonia clinical efficacy worthy of affirmation, better than the efficacy of cefoperazone treatment, safe and effective, worthy of clinical application.